3.47
0.00 (0.00%)
0.00 (0.00%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aptinyx Inc | APTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.02 | 0.58% | 3.47 | 3.41 | 3.58 | 3.45 | 3.45 | 23:59:39 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 3.00 | 5.78 | 2.78 | 48.1% | 2 | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 901 | 195,776 | $ 3.51 | $ 688,085 | 478,186 | 2.61 - 6.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:59:36 | 3,480 | $ 3.47 | USD |
Aptinyx Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 157.44M | 45.37M | $ -53.28M | -2.79 | - | 43.98M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 8.00 | 4.10% |
Aptinyx News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.76 | 3.87 | 3.40 | 3.54 | 314,337 | -0.29 | -7.71% |
| 1 Month | 3.90 | 5.30 | 3.40 | 4.29 | 541,742 | -0.43 | -11.03% |
| 3 Months | 3.18 | 5.30 | 2.90 | 3.96 | 320,462 | 0.29 | 9.12% |
| 6 Months | 3.15 | 5.30 | 2.61 | 3.79 | 200,412 | 0.32 | 10.16% |
| 1 Year | 5.50 | 6.00 | 2.61 | 3.90 | 246,361 | -2.03 | -36.91% |
| 3 Years | 17.40 | 32.25 | 2.61 | 8.17 | 231,250 | -13.93 | -80.06% |
| 5 Years | 17.40 | 32.25 | 2.61 | 8.17 | 231,250 | -13.93 | -80.06% |
Aptinyx Description
| Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Its pipeline products are NYX-2925, NYX-458, and NYX-783. NYX-2925 is a novel, oral, small-molecule NMDA receptor modulator in clinical development as a therapy for chronic pain. NYX-2925 works by enhancing synaptic plasticity, a mechanism uniquely suited to addressing chronic pain, and NYX-783 is an NMDA receptor modulating small molecule in clinical development as a therapy for post-traumatic stress disorder. |
